Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lilly To Acquire Adverum Biotechnologies For Total Per Share Consideration Up To $12.47; Lilly To Commence Tender Offer To Acquire All Shares For Per Share Price Of $3.56 In Cash Plus One CVR Entitling Holder To Receive Up To Additional $8/91 Per CVR In Cash Upon Milestones

Author: Benzinga Newsdesk | October 24, 2025 08:34am

Posted In: ADVM LLY